You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

temozolomide for injection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))

Recruiting
  • Glioblastoma
  • GBM
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Nov 23, 2023

Leiomyosarcoma Trial in Beijing (Temozolomide for injection combined with epirubicin)

Recruiting
  • Leiomyosarcoma
  • Temozolomide for injection combined with epirubicin
  • Beijing, Beijing, China
    Cancer Hospital of Chinese Academy of Medical Sciences
Jan 11, 2022

Malignant Melanoma Trial in Hangzhou (toripalimab, Temozolomide Injection)

Recruiting
  • Malignant Melanoma
  • Hangzhou, Zhejiang, China
    Department of Medical Onocology, First Affiliated Hospital of Zh
May 10, 2021

Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

Recruiting
  • Neuroblastoma
  • Naxitamab monotherapy
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 31, 2023

Glioblastoma, Glioblastoma Multiforme Trial (Ferumoxytol injection, Pharmacological ascorbate, External beam radiation therapy)

Not yet recruiting
  • Glioblastoma
  • Glioblastoma Multiforme
  • Ferumoxytol injection
  • +3 more
  • (no location specified)
Mar 3, 2022

Primary CNS Lymphoma Trial in Zhengzhou (Rituximab, Lenalidomide, Methotrexate)

Recruiting
  • Primary Central Nervous System Lymphoma
  • Zhengzhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 30, 2021

Glioma, Malignant Trial in United States (biological, drug, radiation, other)

Active, not recruiting
  • Glioma, Malignant
  • AdV-tk
  • +5 more
  • Los Angeles, California
  • +7 more
Jan 30, 2023

Cutaneous Melanoma Trial in Worldwide (PV-10 (10% rose bengal disodium), Dacarbazine, temozolomide or talimogene laherparepvec)

Terminated
Has Results
  • Cutaneous Melanoma
  • PV-10 (10% rose bengal disodium)
  • Dacarbazine, temozolomide or talimogene laherparepvec
  • San Diego, California
  • +22 more
Jan 17, 2022

Melanoma, Acral Melanoma, Temozolomide Trial (Camrelizumab)

Not yet recruiting
  • Melanoma
  • +6 more
  • (no location specified)
Aug 21, 2022

Breast Cancer Trial (Pyrotinib, Temozolomide Injection, SHR-1316)

Unknown status
  • Breast Cancer
  • (no location specified)
Mar 9, 2020

Recurrent Glioblastoma, Refractory Glioblastoma Trial in Hangzhou, Huzhou, Ningbo (Temozolomide, B7-H3 CAR-T)

Recruiting
  • Recurrent Glioblastoma
  • Refractory Glioblastoma
  • Hangzhou, Zhejiang, China
  • +2 more
Dec 25, 2022

Newly Diagnosed Glioblastoma Trial in United States (SurVaxM)

Recruiting
  • Newly Diagnosed Glioblastoma
  • SurVaxM
  • San Francisco, California
  • +9 more
Aug 23, 2022

Ewing Sarcoma, Ewing Family of Tumors, Ewing's Tumor Metastatic Trial in United States (Vigil, Irinotecan, Temozolomide)

Active, not recruiting
  • Ewing Sarcoma
  • +12 more
  • Vigil
  • +2 more
  • Little Rock, Arkansas
  • +16 more
Feb 9, 2022

Advanced Glioblastoma, Metastatic Melanoma in the CNS, MGMT-Unmethylated Glioblastoma Trial in Ramat Gan (Crizanlizumab-Tmca 10

Not yet recruiting
  • Advanced Glioblastoma
  • +2 more
  • Crizanlizumab-Tmca 10 MG/1 ML Intravenous Solution [ADAKVEO]
  • Nivolumab 10 MG/1 ML Intravenous Solution [OPDIVO]
  • Ramat Gan, Israel
    Sheba medical center
Jun 11, 2023

Ewing's Sarcoma Trial in United States (Vigil, Temozolomide, Irinotecan)

Completed
Has Results
  • Ewing's Sarcoma
  • Vigil
  • +4 more
  • Little Rock, Arkansas
  • +5 more
Dec 20, 2022

Gliosarcoma, MGMT-Unmethylated Glioblastoma Trial in United States (biological, device, other, radiation, drug)

Suspended
  • Gliosarcoma
  • MGMT-Unmethylated Glioblastoma
  • Ipilimumab
  • +6 more
  • Birmingham, Alabama
  • +285 more
Aug 24, 2022

Glioblastoma Trial in France (Polysiloxane Gd-Chelates based nanoparticles (AGuIX), radiotherapy, Temozolomide)

Recruiting
  • Glioblastoma
  • Polysiloxane Gd-Chelates based nanoparticles (AGuIX)
  • +2 more
  • Brest, France
  • +5 more
Jun 16, 2022

Melanoma Trial in Beijing, Nanjing, Hangzhou (OH2, Salvage chemo or best supportive care)

Recruiting
  • Melanoma
  • OH2
  • Salvage chemotherapy or best supportive care
  • Beijing, Beijing, China
  • +2 more
May 11, 2023

Glioblastoma Trial in Durham (Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF, Temozolomide, Tetanus-Diphtheria

Suspended
  • Glioblastoma
  • Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF
  • +4 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Malignant Tumors of Brain Trial in Durham (tetanus toxoid, therapeutic autologous dendritic cells, therapeutic autologous

Active, not recruiting
  • Malignant Neoplasms of Brain
  • tetanus toxoid
  • +2 more
  • Durham, North Carolina
    Duke University Medical Center
Aug 16, 2022

Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)

Recruiting
  • Glioblastoma Multiforme of Brain
  • Multipeptide plus XS15
  • Tübingen, BW, Germany
    University Hospital Tübingen
May 9, 2022

Brain Tumor Adult Trial in Birmingham (DRI cell therapy)

Recruiting
  • Brain Tumor Adult
  • DRI cell therapy
  • Birmingham, Alabama
    University of Alabama at Birmingham
Feb 1, 2022

Glioblastoma Trial in France (UCPVax, Temozolomide)

Recruiting
  • Glioblastoma
  • Besançon, France
  • +3 more
May 19, 2022

Glioblastoma Multiforme of Brain Trial in Beijing (Autologous dendritic cells pulsed with multiple neoantigen peptides.,

Recruiting
  • Glioblastoma Multiforme of Brain
  • Autologous dendritic cells pulsed with multiple neoantigen peptides.
  • Temozolomide adjuvant chemotherapy
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Jan 13, 2022

Rhabdomyosarcoma, Child Trial (Doxorubicin Hydrochloride Liposome+Irinotecan, Temozolomide+Irinotecan+Vincristine)

Not yet recruiting
  • Rhabdomyosarcoma, Child
  • (no location specified)
Jul 13, 2022